Back to Search
JON PAGEL, PHARMD
PHARMD
Pharmacist
NPI: 1528607587Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
20071-40(WI)5302416159(MI)
Research & Publications (20)
The burden of obstructive sleep apnea and associated excessive sleepiness.
PMID 18687237·J Fam Pract·2008
6-review
Medications for the Treatment of Sleep Disorders: An Overview.
PMID 15014609·Prim Care Companion J Clin Psychiatry·2001
8-other
131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma.
PMID 19332764·Blood·2009
7-preclinical
Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database.
PMID 19308749·Acta Obstet Gynecol Scand·2009
4-observational
Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia.
PMID 19118002·Cancer Res·2009
7-preclinical
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211.
PMID 19244101·Cancer Res·2009
7-preclinical
A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.
PMID 19124831·Blood·2009
4-observational
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates.
PMID 19515724·Blood·2009
4-observational
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.
PMID 18509084·Blood·2008
3-trial
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.
PMID 18623377·Cancer·2008
3-trial
Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.
PMID 18502830·Blood·2008
7-preclinical
Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy.
PMID 18042793·Blood·2008
7-preclinical
Radioimmunotherapeutic approaches for leukemia: the past, present and future.
PMID 18202970·Cytotherapy·2008
6-review
Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.
PMID 18326813·Blood·2008
7-preclinical
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.
PMID 18452065·Leuk Lymphoma·2008
8-other
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.
PMID 18454687·Cancer Biother Radiopharm·2008
7-preclinical
Annual plants under cyclic disturbance regime: better understanding through model aggregation.
PMID 19263893·Ecol Appl·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- N10565 GRANDVIEW LN
IRONWOOD, MI 49938 - Phone
- (906) 932-7080
Quick Facts
- NPI
- 1528607587
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile